Mastering Oncological Emergencies Guidelines for SCE Success

Oncological emergencies are among the most reliable high-yield topics across the Specialty Certificate Examinations (SCE) — whether you are sitting Medical Oncology, Haematology, Acute Internal Medicine, Geriatric Medicine or Palliative Care. Why? Because they are common, guideline-driven and time-critical — the perfect recipe for a discriminator question in a best-of-five (BOF) format. The examiner is not testing whether you know neutropenic sepsis exists; they are testing whether you know the first-line antibiotic, the exact steroid dose, the imaging deadline and the sequence of actions.

This guide distils the NICE and UK guidance you must know for the four classic oncological emergencies: neutropenic sepsis, superior vena cava (SVC) obstruction, metastatic spinal cord compression (MSCC) and tumour lysis syndrome (TLS).

The Big Four at a Glance

1. Neutropenic Sepsis — NICE CG151 and the UK Chemotherapy Board

The definition examiners expect

Neutropenic sepsis is a clinical diagnosis, never one you wait for cultures to confirm:

• Neutrophil count < 0.5 × 10⁹/L (or expected to fall below it), plus

• Temperature ≥ 38°C on a single reading, or other signs consistent with clinically significant sepsis (hypotension, tachycardia, confusion).

Remember afebrile neutropenic sepsis occurs — especially in older patients or those on corticosteroids. Do not be reassured by a normal temperature if the patient looks unwell on chemotherapy.

The first hour — the door-to-needle rule

1. ABCDE assessment and IV access.

2. Blood cultures — peripheral, and from every central line lumen if one is in situ.

3. Baseline bloods: FBC, U&E, LFT, CRP, coagulation, group and save.

4. Empirical antibiotics within 1 hour of presentation — do not delay for imaging or results.

5. CXR only if respiratory symptoms or signs. Do not routinely send urine, stool or sputum cultures in the absence of symptoms.

Empirical antibiotics — the algorithm

• First-line: antipseudomonal beta-lactam monotherapy — piperacillin-tazobactam (e.g. 4.5 g IV). This is the single most tested answer in this topic.

• Alternatives if allergy or local policy: ceftazidime, cefepime or a carbapenem such as meropenem.

• Add an aminoglycoside (e.g. gentamicin) if there is haemodynamic instability.

• Consider adding vancomycin or teicoplanin only if there is: haemodynamic instability, suspected central line infection, known colonisation with resistant organisms (e.g. MRSA), soft-tissue/mucosal infection, or prolonged severe neutropenia already on broad-spectrum therapy.

• Do not use a glycopeptide routinely as initial empirical cover — a favourite wrong answer.

Reassessment and duration

• Reassess at 48–72 hours: de-escalate if the patient is stable and cultures are negative; stop any empirical glycopeptide if no Gram-positive isolate.

• Continue therapy until the patient is clinically improved with marrow recovery — classically afebrile for at least 48 hours with neutrophils rising (typically ≥ 0.5 × 10⁹/L).

MASCC score — the trap inside the trap

The Multinational Association for Supportive Care in Cancer (MASCC) score identifies patients at low risk of complications:

• MASCC ≥ 21 = LOW risk — carefully selected, compliant patients may be managed with oral ciprofloxacin plus amoxicillin as an outpatient (with 24-hour review and written safety-netting).

• MASCC < 21 = HIGH risk — admit for IV antibiotics.

The classic BOF trap: a higher MASCC score means lower risk. Read the question stem twice.

What NOT to do

• Do not use G-CSF routinely in established neutropenic sepsis (no proven mortality benefit).

• Do not delay antibiotics for investigations.

• Do not add vancomycin reflexively.

2. Superior Vena Cava Obstruction

Causes

• Malignant: lung cancer is the commonest cause overall (small cell classically associated, but NSCLC dominates by sheer numbers), followed by lymphoma; also breast cancer, germ-cell tumours and mediastinal metastases.

• Non-malignant: thrombosis related to central venous catheters and pacemaker leads (increasingly common), and mediastinal fibrosis (radiotherapy, TB, histoplasmosis).

Clinical features

Dyspnoea (commonest), facial and arm swelling with plethora, distended neck and chest-wall collateral veins, cough, hoarseness, and symptoms worse on lying flat or bending forward. Pemberton's sign (facial plethora and raised JVP on raising the arms) is the classic eponym. Stridor, laryngeal oedema, cerebral oedema (headache, visual disturbance) or haemodynamic compromise signal severe, life-threatening disease.

Management sequencing — what the SCE actually tests

1. Assess severity. Severe obstruction → endovascular stenting, which gives the fastest relief (hours) — the correct answer when the stem describes stridor, cerebral oedema or a chemoresistant tumour.

2. If not immediately life-threatening, obtain a tissue diagnosis first (biopsy of the mass or a lymph node, pleural fluid cytology, sputum cytology) before definitive therapy.

3. Dexamethasone (typically 4–16 mg daily) provides symptomatic benefit and is part of lymphoma treatment — but beware: giving steroids before biopsy in suspected lymphoma can lyse the tissue and compromise histology. This sequencing dilemma is a recurring SCE theme.

4. Chemotherapy for chemosensitive tumours (small cell lung cancer, lymphoma); radiotherapy for chemoresistant tumours or inadequate response.

5. Thrombotic SVC obstruction: therapeutic anticoagulation per cancer-associated thrombosis guidance and removal of the precipitating line.

6. Diagnosis: contrast-enhanced CT chest is the test of choice.

3. Metastatic Spinal Cord Compression — NICE CG75

MSCC affects 5–10% of cancer patients, and prognosis for walking is largely determined by mobility at the start of treatment: patients ambulatory when treatment begins usually remain ambulatory, while those who are paraplegic rarely walk again. Every time target exists because minutes matter.

Red flags in a cancer patient

• New or worsening back pain — especially thoracic, band-like or radiating, nocturnal, and progressive despite analgesia.

• New limb weakness, gait disturbance or sensory loss.

• Late and ominous: bladder/bowel dysfunction (retention, overflow incontinence, constipation) and saddle anaesthesia.

Imaging time targets — learn these cold

• Neurological signs or symptoms suggesting MSCC → whole-spine MRI immediately (same day, as an emergency).

• Suspicious back pain without neurological signs → whole-spine MRI within 24 hours.

• Whole-spine imaging is essential — disease is frequently multilevel.

• If MRI is contraindicated or unavailable → whole-spine CT.

Dexamethasone

• If MSCC is clinically suspected while awaiting imaging or treatment: dexamethasone 16 mg daily (commonly as a single morning dose) with PPI gastroprotection, tapered once definitive treatment begins (specialist discussion in lymphoma, where steroids are part of treatment).

Definitive treatment

• First definitive treatment (surgery or radiotherapy) within 24 hours of a confirmed diagnosis, unless the MDT documents a reason to deviate.

• Surgery (decompression ± stabilisation): consider when a tissue diagnosis is needed, there is spinal instability, the tumour is radioresistant, or the patient deteriorates despite radiotherapy.

• Radiotherapy: the mainstay for most patients — commonly 20 Gy in 5 fractions (single 8 Gy fraction for those with poor prognosis).

• Bed rest with neutral spine alignment and log-rolling until spinal stability and the treatment plan are established — do not mobilise a patient with suspected unstable MSCC.

• Refer through your local MSCC coordinator pathway — NICE mandates a 24/7 coordination service.

4. Tumour Lysis Syndrome — Cairo-Bishop Criteria

Pathophysiology in one sentence

Rapid tumour-cell lysis — typically 12–72 hours after starting chemotherapy, but occasionally before it (spontaneous TLS in bulky disease) — releases potassium, phosphate and uric acid into the circulation; urate and calcium-phosphate crystals precipitate in renal tubules causing AKI, while hyperkalaemia threatens cardiac rhythm.

Laboratory TLS

Two or more of the following, within 3 days before to 7 days after starting therapy:

Clinical TLS = laboratory TLS + at least one of: AKI (creatinine ≥ 1.5 × ULN), cardiac arrhythmia or sudden death, or seizure.

Risk stratification and prophylaxis

Management of established TLS

• Aggressive IV hydration (typically 2.5–3 L/m²/day if cardio-renal status permits), aiming for high urine output.

• Monitor U&E, urate, phosphate and calcium every 6–12 hours for the first 48–72 hours.

• Treat hyperkalaemia; reserve IV calcium for ECG changes or symptomatic hypocalcaemia — routine calcium worsens calcium-phosphate deposition.

• Continue rasburicase daily (up to 5–7 days) until urate is controlled.

• Dialysis for refractory hyperkalaemia, fluid overload or uraemia.

The do-NOTs examiners adore

• Do not alkalinise urine with routine bicarbonate — it promotes calcium-phosphate precipitation.

• Rasburicase is contraindicated in G6PD deficiency (haemolysis, methaemoglobinaemia) and avoided in pregnancy.

• Allopurinol markedly increases azathioprine and 6-mercaptopurine toxicity — reduce the dose or avoid.

• Febuxostat is an alternative xanthine-oxidase inhibitor — avoid in significant cardiovascular disease.

The Rest of the Emergency Fleet

Quick recognition points for the SCE periphery:

• Hypercalcaemia: rehydrate first, bisphosphonate after; always seek the underlying malignancy.

• Leukostasis (symptomatic hyperleukocytosis, often WCC > 100 × 10⁹/L): hydration, hydroxycarbamide ± leukapheresis; avoid red-cell transfusion until leukostasis is treated (it raises viscosity).

• Neutropenic enterocolitis (typhlitis): neutropenic patient with right iliac fossa pain, diarrhoea ± bleeding; CT shows bowel-wall thickening; treat conservatively with broad-spectrum antibiotics including anaerobic cover — surgery reserved for perforation or uncontrolled bleeding.

• Raised intracranial pressure from brain metastases: dexamethasone and urgent neuro-oncology MDT for surgery, whole-brain radiotherapy or stereotactic radiosurgery.

• Malignant cardiac tamponade: urgent pericardiocentesis.

One-Table Revision: The Numbers SCE Examiners Love

How the SCE Actually Tests This

You will rarely be asked to list a guideline. Instead, expect:

• Time-threshold questions where every option differs only in the number of hours.

• First-line drug selection — piperacillin-tazobactam for neutropenic sepsis; rasburicase versus allopurinol based on TLS risk.

• Sequencing dilemmas — biopsy versus steroids in suspected lymphoma with SVC obstruction; tissue diagnosis versus immediate stenting.

• Inversion traps — higher MASCC score means lower risk; steroids given too early spoil lymphoma histology; G-CSF is not routine treatment; do not alkalinise urine in TLS.

Worked BOF example: A 62-year-old man, day 10 of FOLFOX chemotherapy, presents with temperature 38.4°C, neutrophils 0.3 × 10⁹/L, BP 116/70, no focal symptoms. What is the most appropriate immediate management? The answer: blood cultures (peripheral ± line) followed by empirical piperacillin-tazobactam within one hour — without waiting for culture results or a chest X-ray.

A Revision Strategy That Works

1. Anchor each emergency to a guideline and 3–5 hard numbers (doses, thresholds, time targets) — these are flashcard gold.

2. Practise BOFs daily in short, spaced blocks; oncological emergencies are ideal for spaced repetition because the facts are discrete.

3. Read the NICE CG151 and CG75 quick-reference summaries once — question stems are frequently paraphrased directly from them.

4. Rehearse the sequencing logic aloud: for every emergency, ask yourself — what is the immediate threat to life, and what single action removes it fastest?

Final Thoughts

Oncological emergencies reward candidates who have converted guidelines into reflexes. Learn the big four as stories of escalating deadlines — one hour for antibiotics, same-day MRI for cord compression, 24 hours to definitive treatment, 6–12 hourly bloods for TLS — and you will convert an entire chapter of the SCE blueprint into guaranteed marks. Master the numbers, respect the sequence, and let the guideline do the thinking for you on exam day.